More news and press

Inscripta Announces the First Commercial Shipment of Its Onyx™ Digital Genome Engineering Platform and Closes $150 Million in New Financing
GeneMill at the University of Liverpool receives first benchtop Onyx platform in EuropeFinancing round led by Fidelity and T. Rowe Price funds…
Read More
Inscripta Appoints Sri Kosaraju as President and CEO
Experienced growth-company leader joins as Inscripta embarks on next phase of commercial launch for its Onyx digital genome engineering platform…
Read More
Inscripta Raises $125M in Series D Financing to Accelerate Commercialization of Revolutionary Digital Genome Engineering Platform
New Funding Brings Total Amount Raised by the Company to $259.5 Million…
Read More
Inscripta Launches the World’s First Benchtop Platform for Digital Genome Engineering
The Onyx platform enables scientists to create libraries of millions of precisely engineered single cells in one experiment through a fully…
Read More
Inscripta Is the Presenting Sponsor of SynBioBeta 2019
Company is launching the world’s first benchtop platform for scalable Digital Genome Engineering at the conference…
Read More
Inscripta Appoints Jim Lalonde to Lead Microbial Digital Genome Engineering Business and Portfolio Strategy
Inscripta today named Jim Lalonde, Ph.D. to its management team…
Read More
Inscripta Expands Management Team with Appointment of Three Senior Bioinformatics and Computational Biology Experts
World’s first benchtop platform for scalable digital genome engineering to be launched at SynBioBeta conference in October…
Read More
Inscripta to present first data from its digital genome engineering technology at upcoming synthetic biology conference
Results from a 200,000-edit library of an E. coli biosynthesis pathway show unprecedented scale and variety of edit types…
Read More
Inscripta Appoints Ron McGrath as Chief Financial Officer
Inscripta, developer of the first scalable platform for benchtop digital genome engineering, today announced the appointment of Ron McGrath as…
Read More
Inscripta Completes $20M Expansion of Series C Financing, Increasing Total Round to $105.5M
Continued support of existing investors will fund commercialization efforts, product launch later this year…
Read More
1 of 2